Spots Global Cancer Trial Database for predictive factors
Every month we try and update this database with for predictive factors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC. | NCT05117775 | Head and Neck C... | No intervention... | 18 Years - | Savana Research | |
| Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection | NCT04363632 | Sars-CoV2 Cancer | - | Centre Leon Berard | ||
| Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma | NCT03601689 | Rectal Neoplasm... | rectal resectio... | 18 Years - | Moroccan Society of Surgery | |
| Cancer Predictive Score on Breast MRI | NCT04914494 | Breast Cancer | 18 Years - | University Hospital, Montpellier | ||
| Study of Predictive Factors of Chemoresistance in Ovarian Cancer | NCT02878122 | Ovarian Cancer | Cancer treatmen... | 18 Years - | Rennes University Hospital | |
| Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera | NCT05548062 | Polycythemia Ve... | Hydroxyurea Ruxolitinib | 18 Years - 99 Years | Novartis | |
| Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera | NCT05548062 | Polycythemia Ve... | Hydroxyurea Ruxolitinib | 18 Years - 99 Years | Novartis | |
| Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer | NCT03410784 | Ovarian Cancer | Pembrolizumab Paclitaxel Carboplatin | 18 Years - | National Cancer Institute, Naples | |
| Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma | NCT03601689 | Rectal Neoplasm... | rectal resectio... | 18 Years - | Moroccan Society of Surgery | |
| Study of Predictive Factors of Chemoresistance in Ovarian Cancer | NCT02878122 | Ovarian Cancer | Cancer treatmen... | 18 Years - | Rennes University Hospital | |
| Clinico-biological Data Collection Study of Metastatic Breast Cancer | NCT03958136 | Breast Cancer | Metastasis biop... Biomarkers bloo... Patient Reporte... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | NCT02156362 | Thyroid Cancer | follow up visit | 18 Years - | Hospices Civils de Lyon | |
| Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC. | NCT05117775 | Head and Neck C... | No intervention... | 18 Years - | Savana Research | |
| Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | NCT02156362 | Thyroid Cancer | follow up visit | 18 Years - | Hospices Civils de Lyon | |
| Clinico-biological Data Collection Study of Metastatic Breast Cancer | NCT03958136 | Breast Cancer | Metastasis biop... Biomarkers bloo... Patient Reporte... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab. | NCT05301465 | Gastric Cancer ... | 18 Years - | University of Pisa |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
